J Korean Med Sci.  2006 Apr;21(2):208-211. 10.3346/jkms.2006.21.2.208.

Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease

• Shim YH
• Kim HS
• Sohn S
• Hong YM

• KMID: 1781823
• DOI: http://doi.org/10.3346/jkms.2006.21.2.208

Abstract

Polymorphism of angiotensin converting enzyme (ACE) gene is reported to be associated with ischemic heart disease, hypertrophic cardiomyopathy, and idiopathic dilated cardiomyopathy. In this study, we investigated the relationship between Kawasaki disease and insertion/deletion polymorphism of ACE gene. Fifty five Kawasaki disease patients and 43 healthy children were enrolled. ACE genotype was evaluated from each of the subjects' DNA fragments through polymerase chain reaction (PCR). Frequencies of ACE genotypes (DD, ID, II) were 12.7%, 60.0%, 27.3% in Kawasaki group, and 41.9%, 30.2%, 27.9% in control group respectively, indicating low rate of DD and high rate of ID genotype among Kawasaki patients (p<0.01). Comparing allelic (I, D) frequencies, I allele was more prevalent in Kawasaki group than in control group (57.3% vs. 43.0%, p<0.05). In Kawasaki group, both genotype and allelic frequencies were not statistically different between those with coronary dilatations and those without. ACE gene I/D polymorphism is thought to be associated with Kawasaki disease but not with the development of coronary dilatations.

Keyword

Mucocutaneous Lymph Node Syndrome; Kawasaki Disease; Peptidyl-Dipeptidase A; Angiotensin Converting Enzyme; Polymorphism; Genetic

MeSH Terms

*Polymorphism, Genetic
Peptidyl-Dipeptidase A/*genetics
Mucocutaneous Lymph Node Syndrome/*enzymology/*genetics/pathology
Male
Infant
Humans
Genotype
Gene Frequency
Female
Dilatation, Pathologic
Coronary Vessels/pathology
Child, Preschool
Case-Control Studies
Alleles

Reference

1. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr. 2004. 16:508–514.

2. Yanagawa H, Yashiro M, Nakamura Y. 14th nationwide survey on Kawasaki disease. J Pediatr Practice. 1998. 61:406–420.

3. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet. 1986. 2:545–546.

4. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human Coronavirus and Kawasaki disease. J Infect Dis. 2005. 191:499–502.

5. Chou CT, Chang JS, Ooi SE, Huo AP, Chang SJ, Chang HN, Tsai CY. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease. Arch Med Res. 2005. 36:14–18.

6. Hagiwara K, Komura H, Kishi P, Kaji T, Yoshida T. Isolation of human herpesvirus-6 from an infant with Kawasaki disease. Eur J Pediatr. 1992. 151:867–868.

7. Baba K, Takeda N, Tanaka M. Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease. Contrib Microbiol Immunol. 1991. 12:292–296.

8. Lee DH, Huang HP. Kawasaki disease associated with chickenpox: report of two sibling cases. Acta Paediatr Taiwan. 2004. 45:94–96.

9. Kang JH, Lee JS. The role of EBV in the development of Kawasaki disease. 1997. In : 5th West-Pacific allergy symposium; 241–244.

10. Rocholl C, Gerber K, Daly J, Pavia AT, Byington CL. Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics. 2004. 113:e51–e56.

11. Kim DS. Immunologic aspect in Kawasaki disease. J Korean Pediatr Cardiol Soc. 2003. 7:306–310.

12. Rowley AH, Shulman ST. Kawasaki syndrome. Pediatrc Clin N Am. 1999. 46:313–329.

13. Wu SF, Chang JS, Peng CT, Shi YR, Tsai FJ. Polymorphism of angiotenisn-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol. 2004. 25:529–533.

14. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem. 1991. 266:15377–15383.

15. Manning MW, Cassis LA, Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2003. 23:483–488.

16. Lamblin N, Hermant X, Lablanche JM, Helbecque N, Amouyel P, Bauters C. Angiotensin converting enzyme and angiotensin II type I receptor polymorphisms in patients with coronary aneurysms. Thromb J. 2003. 1:5–11.

17. Prasad A, Narayanan S, Waclawiw MA, Epstein N, Quyyumi AA. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity. J Am Coll Cardiol. 2000. 36:1579–1586.

18. Scheer WD, Boudreau DA, Hixson JE, McGill HC, Newman WP 3rd, Tracy RE, Zieske AW, Stong JP. ACE insert/delete polymorphism and atherosclerosis. Atherosclerosis. 2005. 178:241–247.

19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990. 86:1343–1346.

20. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992. 51:197–205.

21. Frossard PM, Lestringant GG, Obineche EN, Hill SH. The angiotensin-converting enzyme (ACE) gene insertion/deletion dimorphism tracks with higher serum ACE activities in both younger and older subjects. Ann Saudi Med. 1998. 18:289–392.

22. Danser AH, Schunkert H. Renin-angiotensin system gene polymorphism: potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol. 2000. 410:303–316.

23. Caldwell PR, Segal BC, Hsu KC, Das M, Softer RL. Angiotensin converting enzyme: vascular endothelial localization. Science. 1976. 191:1050–1051.

24. Falcini F, Generini S, Pigone A, Leoncini G, Cimaz R, Partsch G, Matucci-Cerinic M. Are angiotensin converting enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease. Endothelium. 1999. 6:209–215.

25. Fukazawa R, Sonobe T, Hamamoto K, Hamaoka K, Sakata K, Asano T, Imai T, Kamisago M, Ohkubo T, Uchikoba Y, Ikegami E, Watanabe M, Ogawa S. Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res. 2004. 56:597–601.

26. Slowik A, Borratynsky A, Pera J, Betlej M, Dziedzic T, Krzyszkowski T, Czepko R, Figlewicz DA, Szczudlik A. II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke. 2004. 35:1594–1597.

27. Takeuchi K, Yamamoto K, Kataoka S, Kakihara T, Tanaki A, Sato S, Uchiyama M. High incidence of angiotensin 1 converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr. 1997. 156:266–268.